Assessing for Cognitive Impairment in Patients
To determine if a patient has cognitive impairment, you must identify abnormalities in at least two of three key assessment areas: cognitive symptoms (reported by patient or observer), low performance on cognitive testing, and evidence of brain injury on neurological investigations. 1
Three-Domain Assessment Framework
The most current consensus approach (2023) requires a comprehensive evaluation across multiple domains, as no single measure is sufficient:
1. Cognitive Symptoms Assessment
- Obtain clinical history from both patient AND an observer (family member, partner, caregiver) whenever possible 1
- Ask specifically about:
- Changes in memory noticed by the patient or others
- Difficulty concentrating or finding words
- Changes in speed of thinking and acting
- Impact on work ability or quality of life (even if not yet affecting basic daily activities)
- Missed appointments or difficulty following instructions
- Decline in self-care or being victimized by financial scams 2, 3
Critical caveat: Cognitive symptoms are inherently subjective and vary by culture, language, and patient insight. Cognitive dysfunction itself can impair a patient's ability to recognize their own deficits, making collateral history essential 1.
2. Objective Cognitive Testing
For rapid screening (5 minutes):
- Montreal Cognitive Assessment (MoCA) subtests: 5-word memory task, 6-item orientation, 1-letter phonemic fluency 2
- Mini-Cog or Memory Impairment Screen plus clock drawing test 3
For more comprehensive assessment (30-60 minutes):
- Evaluate multiple domains: executive/activation function, language, visuospatial abilities, and memory 2
- Timed executive function tests are especially sensitive to cognitive impairment as they capture slowed information processing 2
Important limitation: Test results are strongly influenced by education, socioeconomic factors, age, and cultural background—interpret in context of the individual's baseline 1.
3. Evidence of Brain Injury
- Neuroimaging (MRI preferred) to identify structural abnormalities 4
- Consider CSF examination when available
- Look for treatable causes: subdural hematomas, masses, normal pressure hydrocephalus, vascular disease 4
Key caveat: Neurological investigations can be insensitive and may show subclinical damage without clinical correlates. Normal imaging does NOT exclude cognitive impairment 1.
Diagnostic Algorithm
Cognitive impairment is present when abnormalities exist in ≥2 of the 3 assessment areas:
- Cognitive symptoms + Low test performance = Cognitive impairment
- Cognitive symptoms + Brain injury evidence = Cognitive impairment (even with normal test scores—important for high-functioning individuals with cognitive reserve) 1
- Low test performance + Brain injury evidence = Cognitive impairment
If only ONE domain is abnormal:
- Low test performance alone = "Low performance on cognitive tests" (NOT cognitive impairment) 1
- This group still has clinical importance but requires different terminology and monitoring
Essential Screening for Reversible Causes
Before diagnosing primary cognitive impairment, screen for and address:
- Depression, anxiety, or other psychiatric conditions 2, 5, 3
- Pain and fatigue 5
- Sleep disturbance (including untreated sleep apnea) 3
- Medications causing cognitive effects (review ALL medications including over-the-counter) 5
- Metabolic derangements, vitamin deficiencies 2
- Delirium (acute, fluctuating presentation) 4
Distinguishing Severity Levels
Mild Cognitive Impairment (MCI):
- Impairment in one or several cognitive domains
- Minimal interference with daily living and functioning 4
- Does NOT meet criteria for dementia
- Noticeable cognitive change but not yet substantially affecting activities of daily living 1
Dementia:
- Significant impairment in ≥2 cognitive domains
- Interferes with ability to function at work or usual activities
- Represents decline from previous level 4
Common Pitfalls to Avoid
Don't rely on subjective impression alone—cognitive symptoms without objective confirmation may reflect depression, anxiety, or normal aging 1
Don't assume normal brief screening = no impairment—Mini-Mental State Examination (MMSE) lacks sensitivity for subtle decline and is affected by age and education 6
Don't overlook the need for collateral history—patients with cognitive impairment often lack insight into their deficits 1
Don't diagnose based solely on biomarkers in asymptomatic individuals—this is ethically problematic and clinically unreliable without supporting clinical evidence 7
Rapidly evolving symptoms require urgent investigation for CNS infection, stroke, or other acute processes 1